Exact Mass: 375.1642

Gatifloxacin

C19H22FN3O4 (375.1594)

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar. Gatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy. [Wikipedia] J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D004791 - Enzyme Inhibitors

6-O-methyl-N-deacetylisoipecoside aglycon

C20H25NO6 (375.1682)

2-Propenamide, N-methyl-N-((3-methyl-2-benzofuranyl)methyl)-3-(5,6,7,8-tetrahydro-7-oxo-1,8-naphthyridin-3-yl)-, (2E)-

C22H21N3O3 (375.1583)

Theodrenaline

C17H21N5O5 (375.1543)

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Afn-1252

C22H21N3O3 (375.1583)

Seneciphyllinine

C20H25NO6 (375.1682)

Acetylseneciphylline is a pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen has been replaced by an acetyl group. It has a role as a Jacobaea metabolite. It is a macrocyclic lactone, an olefinic compound, an organic heterotricyclic compound, a pyrrolizine alkaloid and an acetate ester. It is functionally related to a seneciphylline. CID 15120074 is a natural product found in Senecio rodriguezii and Senecio pterophorus with data available. A pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen has been replaced by an acetyl group.

Isolonganone

C20H25NO6 (375.1682)

3-O-Acetylnarcissidine

C20H25NO6 (375.1682)

UCS1025B

C20H25NO6 (375.1682)

Acetylspartioidine

C20H25NO6 (375.1682)

NM-2201

C24H22FNO2 (375.1634)

4-(4,6-dimethyl-9-oxo-4,9-dihydro-1H-imidazo[1,2-a]pyrrolo[3,2-d]pyrimidin-7-yl)-2-methoxycarbonylamino-butyric acid methyl ester

C17H21N5O5 (375.1543)

almazole D

C22H21N3O3 (375.1583)

N1-demethyl cynodine

C22H21N3O3 (375.1583)

Cystodytins-Cystodytin C

C22H21N3O3 (375.1583)

N1-Demethylcynodine

C22H21N3O3 (375.1583)

taiwanamide C

C20H25NO6 (375.1682)

cystodytin C

C22H21N3O3 (375.1583)

2alpha,7-dimethoxyhomolycorine

C20H25NO6 (375.1682)

penispirolloid A

C21H21N5O2 (375.1695)

(13bS)-4-acetyl-8,13,13b,14-tetrahydro-1-(1-hydroxyethyl)indolo[2,3:3,4]pyrido[1,2-b] [2,7]naphthyridin-5(7H)-one|Latifoliamide E

C22H21N3O3 (375.1583)

SCHEMBL13335152

C26H21N3 (375.1735)

10,16-dioxo-16,19-seco-strychnidine-19-carbonitrile|N-Cyano-sec-pseudostrychnin|N-Cyano-sec-pseudostrychnine

C22H21N3O3 (375.1583)

3,3,3-methanetriyltris(1H-indole)

C26H21N3 (375.1735)

SCHEMBL13025211

C20H25NO6 (375.1682)

Gly Tyr His

C17H21N5O5 (375.1543)

Tyr Gly His

C17H21N5O5 (375.1543)

Tyr His Gly

C17H21N5O5 (375.1543)

Leu Asp Asp

C15H25N3O8 (375.1642)

Val Glu Glu

C15H25N3O8 (375.1642)

Asp Asp Leu

C15H25N3O8 (375.1642)

Ile Asp Glu

C15H25N3O8 (375.1642)

SCHEMBL18797432

C15H25N3O8 (375.1642)

Glu Val Glu

C15H25N3O8 (375.1642)

AM2201 7-hydroxyindole metabolite

C24H22FNO2 (375.1634)

Glu Asp Ile

C15H25N3O8 (375.1642)

Asp Leu Asp

C15H25N3O8 (375.1642)

His Gly Tyr

C17H21N5O5 (375.1543)

AM2201 6-hydroxyindole metabolite

C24H22FNO2 (375.1634)

Trp Asn Gly

C17H21N5O5 (375.1543)

AM2201 N-(4-hydroxypentyl) metabolite

C24H22FNO2 (375.1634)

Asp Ile Glu

C15H25N3O8 (375.1642)

Glu Ile Asp

C15H25N3O8 (375.1642)

Gly His Tyr

C17H21N5O5 (375.1543)

Asp Glu Ile

C15H25N3O8 (375.1642)

bisIMI

C26H21N3 (375.1735)

2,3-Bis(3-indolylmethyl)indole significantly suppresses RANKL-induced osteoclast formation, actin ring formation, and bone resorption in a concentration-dependent manner.

Gatifloxacin

C19H22FN3O4 (375.1594)

A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D004791 - Enzyme Inhibitors

Gly Gly Gly Trp

C17H21N5O5 (375.1543)

Gly Gly Trp Gly

C17H21N5O5 (375.1543)

Gly Trp Gly Gly

C17H21N5O5 (375.1543)

Trp Gly Asn

C17H21N5O5 (375.1543)

His Tyr Gly

C17H21N5O5 (375.1543)

Ile Glu Asp

C15H25N3O8 (375.1642)

Glu Asp Leu

C15H25N3O8 (375.1642)

Gly Trp Asn

C17H21N5O5 (375.1543)

Glu Glu Val

C15H25N3O8 (375.1642)

Asp Glu Leu

C15H25N3O8 (375.1642)

Asn Gly Trp

C17H21N5O5 (375.1543)

Leu Asp Glu

C15H25N3O8 (375.1642)

Gly Asn Trp

C17H21N5O5 (375.1543)

Asn Trp Gly

C17H21N5O5 (375.1543)

Leu Glu Asp

C15H25N3O8 (375.1642)

Glu Leu Asp

C15H25N3O8 (375.1642)

Asp Leu Glu

C15H25N3O8 (375.1642)

Trp Gly Gly Gly

C17H21N5O5 (375.1543)

Urea, N-[(2-chloro-6-ethoxy-3-quinolinyl)methyl]-N-cyclopentyl-N,N-dimethyl- (9CI)

C20H26ClN3O2 (375.1713)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-methoxyphenyl)- (9CI)

C21H21N5O2 (375.1695)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(3-methoxyphenyl)- (9CI)

C21H21N5O2 (375.1695)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-methoxyphenyl)- (9CI)

C21H21N5O2 (375.1695)

Urea, N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]-N-(4-methoxyphenyl)- (9CI)

C21H21N5O2 (375.1695)

Urea, N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]-N-(3-methoxyphenyl)- (9CI)

C21H21N5O2 (375.1695)

Urea, N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]-N-(2-methoxyphenyl)- (9CI)

C21H21N5O2 (375.1695)

METHYL 9-[METHYL-4-(TRIFLUOROMETHOXY)ANILINO]-9-OXONONANOATE

C18H24F3NO4 (375.1657)

(S)-Ketoprofen trometamol

C20H25NO6 (375.1682)

4-aminodibenzo-18-crown-6

C20H25NO6 (375.1682)

Nalmefene hydrochloride

C21H26ClNO3 (375.1601)

D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

Ciprofloxacin-D8 hydrochloride hydrate (see Data Sheet)

C17H11ClD8FN3O3 (375.1601)

MI-3

C18H25N5S2 (375.1551)

Piclopastine

C20H26ClN3O2 (375.1713)

2,2-IMinobis(N-(2,6-Dimethylphenyl)acetiamide Hydrochloride

C20H26ClN3O2 (375.1713)

Trelagliptin Impurity X

C18H22FN5O3 (375.1707)

Pipethanate hydrochloride

C21H26ClNO3 (375.1601)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

4-(4-(5,5-Dimethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-propylthieno[2,3-d]pyrimidine

C18H25N5S2 (375.1551)

Levoflaxacin

C19H22FN3O4 (375.1594)

1-(2-(4-Azidophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine

C19H20F3N5 (375.1671)

L-Histidyl-L-tyrosylglycine

C17H21N5O5 (375.1543)

JWH 412 N-(5-hydroxypentyl) metabolite

C24H22FNO2 (375.1634)

(6,7-Difluoro-quinazolin-4-YL)-(1-methyl-2,2-diphenyl-ethyl)-amine

C23H19F2N3 (375.1547)

Theodrenaline

C17H21N5O5 (375.1543)

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

1-cyclopropyl-6-fluoro-8-methoxy-7-[(3S)-3-methylpiperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C19H22FN3O4 (375.1594)

(R)-gatifloxacin

C19H22FN3O4 (375.1594)

The (R)-enantiomer of gatifloxacin.

Glu-Asp-Leu

C15H25N3O8 (375.1642)

Glu-Asp-Ile

C15H25N3O8 (375.1642)

A tripeptide composed of L-glutamic acid, L-aspartic acid and L-isoleucine joined in sequence by peptide linkages.

4-[[4-(Dimethylamino)-7,7-dimethyl-6,8-dihydropyrimido[4,5-b][1,4]benzothiazin-9-yl]amino]butanoic acid

C18H25N5O2S (375.1729)

3-[(4-ethoxyphenoxy)methyl]-N-(3-pyridinylmethylene)benzohydrazide

C22H21N3O3 (375.1583)

Asp-Glu-Leu

C15H25N3O8 (375.1642)

Glu-Glu-Val

C15H25N3O8 (375.1642)

1-(4-methylphenyl)spiro[1,3-diazinane-5,4-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-a]quinoline]-2,4,6-trione

C22H21N3O3 (375.1583)

(5Z)-5-[(E)-3-(4-dimethylaminophenyl)prop-2-enylidene]-1-(4-methylphenyl)-1,3-diazinane-2,4,6-trione

C22H21N3O3 (375.1583)

3,7-Dimethyl-1-(phenylmethyl)-8-[(phenylmethyl)amino]purine-2,6-dione

C21H21N5O2 (375.1695)

N-(4-ethoxyphenyl)-1,5-dimethyl-4-oxo-2-pyrrolo[3,2-c]quinolinecarboxamide

C22H21N3O3 (375.1583)

2-{2-[(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]hydrazino}-2-oxo-N-(2-pyridinylmethyl)acetamide

C21H21N5O2 (375.1695)

2-[[(5-Tert-butyl-2-methyl-3-furanyl)-oxomethyl]amino]-4,5-dimethoxybenzoic acid methyl ester

C20H25NO6 (375.1682)

(2E)-3-(4-methoxyphenyl)-N-(11-oxo-6,8,9,11-tetrahydro-7H-pyrido[2,1-b]quinazolin-2-yl)acrylamide

C22H21N3O3 (375.1583)

Val-Glu-Glu

C15H25N3O8 (375.1642)

Asp-Ile-Glu

C15H25N3O8 (375.1642)

Asp-Leu-Glu

C15H25N3O8 (375.1642)

Glu-Val-Glu

C15H25N3O8 (375.1642)

Trp-Gly-Asn

C17H21N5O5 (375.1543)

N-[2-(dimethylamino)ethyl]-N-([1,3]dioxolo[4,5-f][1,3]benzothiazol-6-yl)cyclohexanecarboxamide

C19H25N3O3S (375.1617)

2-[(1R,3R,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C20H25NO6 (375.1682)

2-[(1R,3S,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C20H25NO6 (375.1682)

2-[(1S,3R,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C20H25NO6 (375.1682)

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

N-[[(2R,3R,4S)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

2-[(1S,3S,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C20H25NO6 (375.1682)

2-[(1R,3R,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C20H25NO6 (375.1682)

2-[(1S,3S,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C20H25NO6 (375.1682)

N-[[(2S,3R,4R)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

N-[[(2S,3S,4R)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

N-[[(2R,3S,4S)-4-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylmethanesulfonamide

C19H25N3O3S (375.1617)

Gly-Asn-Trp

C17H21N5O5 (375.1543)

Asn-Trp-Gly

C17H21N5O5 (375.1543)

Asp-Glu-Ile

C15H25N3O8 (375.1642)

Glu-Ile-Asp

C15H25N3O8 (375.1642)

Gly-Trp-Asn

C17H21N5O5 (375.1543)

His-Gly-Tyr

C17H21N5O5 (375.1543)

Ile-Asp-Glu

C15H25N3O8 (375.1642)

Asn-Gly-Trp

C17H21N5O5 (375.1543)

Glu-Leu-Asp

C15H25N3O8 (375.1642)

Gly-His-Tyr

C17H21N5O5 (375.1543)

Gly-Tyr-His

C17H21N5O5 (375.1543)

Ile-Glu-Asp

C15H25N3O8 (375.1642)

Leu-Asp-Glu

C15H25N3O8 (375.1642)

Leu-Glu-Asp

C15H25N3O8 (375.1642)

Trp-Asn-Gly

C17H21N5O5 (375.1543)

Tyr-Gly-His

C17H21N5O5 (375.1543)

Tyr-His-Gly

C17H21N5O5 (375.1543)

Octyl 5-methyl-7-thiophen-2-yl-6,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate

C18H25N5O2S (375.1729)

3-(3,4-dimethoxyphenyl)-N-[2-(1-hydroxy-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl)ethyl]propanamide

C20H25NO6 (375.1682)

(S)-gatifloxacin

C19H22FN3O4 (375.1594)

The (S)-enantiomer of gatifloxacin.

6-O-Methyl-N-deacetylipecoside aglycone

C20H25NO6 (375.1682)

His-Tyr-Gly

C17H21N5O5 (375.1543)

ST 18:4;O4;Gly

C20H25NO6 (375.1682)

(2s,3s)-2-{[(2s)-2-{[(2s)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-3-carboxy-1-hydroxypropylidene]amino}-3-methylpentanoic acid

C15H25N3O8 (375.1642)

3,10-dihydroxy-3-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-5-oxa-1-azatricyclo[5.2.1.0⁴,¹⁰]decane-2,6-dione

C20H25NO6 (375.1682)

(1r,4e,7r,17r)-4-ethylidene-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

C20H25NO6 (375.1682)

4-ethylidene-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

C20H25NO6 (375.1682)

(1r,4z,7r,17r)-4-ethylidene-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

C20H25NO6 (375.1682)

15-hydroxy-4,5,14-trimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,11-tetraen-13-yl acetate

C20H25NO6 (375.1682)

(1s,10s,11r,12s,22r)-20,23-dioxo-9-oxa-4,13-diazahexacyclo[9.8.3.2¹⁰,¹³.0¹,¹².0⁶,²².0¹⁴,¹⁹]tetracosa-6,14,16,18-tetraene-4-carbonitrile

C22H21N3O3 (375.1583)

(1s,13r,14r,15s,16s)-15-hydroxy-4,5,14-trimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,11-tetraen-13-yl acetate

C20H25NO6 (375.1682)

(3r,4s,7r,10r)-3-[(1r,2s,4as,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-3,10-dihydroxy-5-oxa-1-azatricyclo[5.2.1.0⁴,¹⁰]decane-2,6-dione

C20H25NO6 (375.1682)

20,23-dioxo-9-oxa-4,13-diazahexacyclo[9.8.3.2¹⁰,¹³.0¹,¹².0⁶,²².0¹⁴,¹⁹]tetracosa-6,14,16,18-tetraene-4-carbonitrile

C22H21N3O3 (375.1583)

(5e,8's,9's)-4-hydroxy-5-(3h-imidazol-4-ylmethylidene)-9'-(3-methylbut-2-en-1-yl)-1h-1'-azaspiro[imidazole-2,11'-tricyclo[6.2.1.0²,⁷]undecane]-2',4',6'-trien-10'-one

C21H21N5O2 (375.1695)

[4-(3h-imidazol-4-yl)-1-methyl-2-oxopyrrolidin-3-yl](phenyl)methyl benzoate

C22H21N3O3 (375.1583)

8-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid

C20H25NO6 (375.1682)

4-(1h-imidazol-4-ylmethylidene)-9'-(3-methylbut-2-en-1-yl)-1'-azaspiro[imidazolidine-2,11'-tricyclo[6.2.1.0²,⁷]undecane]-2',4',6'-triene-5,10'-dione

C21H21N5O2 (375.1695)

(1s,8s,10s,11r,12r)-3-hydroxy-4,11,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-13-one

C20H25NO6 (375.1682)

(1s,4z,7s,17s)-4-ethylidene-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

C20H25NO6 (375.1682)

(7r,8r)-8-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4,8-dimethoxy-5h,6h,7h-furo[2,3-b]quinolin-7-yl acetate

C20H25NO6 (375.1682)

2,5-dimethoxy-n-[2-(3,4,5-trimethoxyphenyl)ethyl]benzenecarboximidic acid

C20H25NO6 (375.1682)

8-(3-hydroxy-3-methylbut-1-en-1-yl)-4,8-dimethoxy-5h,6h,7h-furo[2,3-b]quinolin-7-yl acetate

C20H25NO6 (375.1682)

(1s,10s,11s,17s)-4,5,6,11-tetramethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-8-one

C20H25NO6 (375.1682)

(s)-[(3s,4r)-4-(3h-imidazol-4-yl)-1-methyl-2-oxopyrrolidin-3-yl](phenyl)methyl benzoate

C22H21N3O3 (375.1583)

(2e,6e)-8-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid

C20H25NO6 (375.1682)